Mani Mohindru does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cara Therapeutics, Inc., CURIS INC, CytomX Therapeutics, Inc., and Cardiff Oncology, Inc..
2019 was Mani Mohindru's most active year for acquiring shares with 5 total transactions. Mani Mohindru's most active month to acquire stocks was the month of May. 2019 was Mani Mohindru's most active year for disposing of shares, totalling 6 transactions. Mani Mohindru's most active month to dispose stocks was the month of February. 2019 saw Mani Mohindru paying a total of $751,816.32 for 145,138 shares, this is the most they've acquired in one year. In 2019 Mani Mohindru cashed out on 114,195 shares for a total of $1,376,941.11, their largest year based on trade value.